30.09.2016 – The 8th International Biotechnology Meeting, hosted at the BEC Barakaldo (Bilbao), coincided with European Biotech Week

Investors from 11 countries study 30 Spanish biotechnology projects

• 46 investors have attended the eigth edition of Biospain, including Edmond de Rothschild Investment Partners, Forbion, Johnson & Johnson Innovation, Novartis Venture Fund, Ysios Capital Partners, Caixa Capital Risc and Cross Road Biotech

• Biospain 2016 further consolidates its position as the fifth biggest event for business meetings, with 2,970 one-to-one meetings taking place

• The event was attended by 1,750 individuals and 701 entities from 29 countries, meaning there was an international presence of 28%

• 233 exhibitors came together for the event, with more exhibition space than at the previous edition

• 84.81% of survey respondents claimed to have identified real business opportunities